TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Catherine Lacombe William Vainchenker Eric Delabesse Véronique Gelsi-Boyer Michaela Fontenay Pierre Fenaux Olivier Kosmider Eric Solary Meyling H Cheok Odile Beyne-Rauzy Daniel Birnbaum Norbert Vey Veronique Della-Valle Groupe Francophone des Myelodysplasies (GFM) Bruno Quesnel Claude Preudhomme Olivier Bernard |
| Publication date | August 7, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |